Home > > > Report Detail

Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 - 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

Publisher Name :
Date: 18-Feb-2019
No. of pages: 105

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025.

“Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscape, and discusses major trends. The report offers the most up-to-date industry data on the actual market situation, and future outlook for global human immunodeficiency virus (HIV) drugs market. The report includes historical data from 2015 to 2018, and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global human immunodeficiency virus (HIV) drugs market. The report explores detailed analysis of top 22 HIV drugs market assessment globally from 2015 to 2018 and forecasts to 2025. The report also details the latest happenings about the global research & development of HIV drugs.

Additionally, the report includes an assessment of clinical trials and promising human immunodeficiency virus (HIV) drugs in clinical development. Key trends in terms of collaboration, partnerships, and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global human immunodeficiency virus (HIV) drugs market.

The report concludes with the profiles of major players in the global human immunodeficiency virus (HIV) drugs market. The key market players are evaluated on various parameters such as business overview and recent development.

The Major Companies Dominating this Market for its Drugs, Services and Continuous Drugs Developments are:


  • AbbVie

  • Merck

  • Gilead Sciences

  • Bristol–Myers Squibb

  • Janssen (Johnson&Johnson)

  • GlaxoSmithKline (GSK)


Top 22 Human Immunodeficiency Virus (HIV) Drugs Covered Under this Report are:


  • Tivicay

  • Triumeq

  • Juluca

  • Epzicom

  • Selzentry

  • Kaletra

  • Sustiva

  • Reyataz

  • Atripla

  • Truvada

  • Viread

  • Complera

  • Stribild

  • Genvoya

  • Biktarvy

  • Descovy

  • Odefsey

  • Prezista/Prezcobix

  • Edurant

  • Isentress

  • Pifeltro

  • Delstrigo


The Latest Industry Data Included in this Report:


  • Global HIV Drugs Market Size & Analysis (2015 – 2025)

  • Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 – 2025

  • Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 – 2025)

  • Promising HIV Drugs in Clinical Development

  • HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018

  • Major Deals (Key Agreements, Partnerships & Collaborations)

  • Latest Happenings in Global HIV Drugs Market

  • Key Drivers & Inhibitors of the Global HIV Drugs Market

  • Major Companies Analysis


The Answers to the Following Key Questions can be found in the Report:


  • What is the size of the global HIV drugs market during 2015 -2025?

  • What will be the revenue generated by each drug during the forecast period?

  • Which major drug provides the highest market share?

  • How are the overall market and major drugs growing?

  • What are the key drivers and inhibitors in the current market?

  • What will be the impact of drivers and inhibitors in the future?

  • How is the market predicted to develop in the future?

  • Who are the key players in this market space?

Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 - 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

Table of Contents

1. Executive Summary

2. Global HIV Drugs Market Size & Analysis (2015 – 2025)

3. Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 – 2025

4. Latest Happenings in Global HIV Drugs Market

5. Key Drivers & Inhibitors of the Global HIV Drugs Market
5.1 Market Drivers
5.2 Inhibitors

6. Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 – 2025)
6.1 Tivicay (dolutegravir)
6.2 Triumeq (dolutegravir/abacavir/lamivudine)
6.3 Juluca (dolutegravir and rilpivirine)
6.4 Epzicom (abacavir and lamivudine)
6.5 Selzentry (maraviroc)
6.6 Kaletra (Iopinavir/ritonavir)
6.7 Sustiva (efavirenz)
6.8 Reyataz (atazanavir)
6.9 Atripla (efavirenz/emtricitabine/tenofovir)
6.10 Truvada (emtricitabine/tenofovir disoproxil fumarate)
6.11 Viread (tenofovir disoproxil fumarate)
6.12 Complera (emtricitabine, rilpivirine, and tenofovir disoproxil fumarate)
6.13 Stribild (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate)
6.14 Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)
6.15 Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide)
6.16 Descovy (emtricitabine and tenofovir alafenamide)
6.17 Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide)
6.18 Prezista/Prezcobix (darunavir ethanolate /cobicistat)
6.19 Edurant (rilpivirine)
6.20 Isentress (raltegravir)
6.21 Pifeltro (doravirine)
6.22 Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate)

7. Partnerships, Collaboration & Licensing Agreement in Global HIV Drugs Market

8. Promising HIV Drugs in Clinical Development

9. HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018

10. Key Companies Analysis
10.1 AbbVie
10.1.1 Business Overview
10.1.2 Recent Development
10.2 GlaxoSmithKline (GSK)
10.2.1 Business Overview
10.2.2 Recent Development
10.3 Gilead Sciences
10.3.1 Business Overview
10.3.2 Recent Development
10.4 Merck
10.4.1 Business Overview
10.4.2 Recent Development
10.5 Bristol Myers Squibb
10.5.1 Business Overview
10.5.2 Recent Development
10.6 Janssen (Johnson & Johnson)
10.6.1 Business Overview
10.6.2 Recent Development

List of Tables

Table 3–1: Global HIV Drugs Market Share & Y–o–Y Growth (%), 2015 – 2018
Table 3–2: Global HIV Drugs Market Share & Y–o–Y Growth Forecast (%), 2019 – 2025
Table 7–1: Partnerships, Collaboration & Licensing Agreement in Global HIV Drugs Market

List of Figures

Figure 2–1: Global HIV Drugs Market Size (Million US$),2015 – 2018
Figure 2–2: Global HIV Drugs Market Size Forecast (Million US$),2019 – 2025
Figure 6–1: Global Tivicay Market Value (Million US$),2015 – 2018
Figure 6–2: Global Tivicay Market Value Forecast (Million US$),2019 – 2025
Figure 6–3: Global Triumeq Market Value (Million US$),2015 – 2018
Figure 6–4: Global Triumeq Market Value Forecast (Million US$),2019 – 2025
Figure 6–5: Global Juluca Market Value (Million US$),2015 – 2018
Figure 6–6: Global Juluca Market Value Forecast (Million US$),2019 – 2025
Figure 6–7: Global Epzicom Market Value (Million US$),2015 – 2018
Figure 6–8: Global Epzicom Market Value Forecast (Million US$),2019 – 2025
Figure 6–9: Global Selzentry Market Value (Million US$),2015 – 2018
Figure 6–10: Global Selzentry Market Value Forecast (Million US$),2019 – 2025
Figure 6–11: Global Kaletra Market Value (Million US$),2015 – 2018
Figure 6–12: Global Kaletra Market Value Forecast (Million US$),2019 – 2025
Figure 6–13: Global Sustiva Market Value (Million US$),2015 – 2018
Figure 6–14: Global Sustiva Market Value Forecast (Million US$),2019 – 2025
Figure 6–15: Global Reyataz Market Value (Million US$),2015 – 2018
Figure 6–16: Global Reyataz Market Value Forecast (Million US$),2019 – 2025
Figure 6–17: Global Atripla Market Value (Million US$),2015 – 2018
Figure 6–18: Global Atripla Market Value Forecast (Million US$),2019 – 2025
Figure 6–19: Global Truvada Market Value (Million US$),2015 – 2018
Figure 6–20: Global Truvada Market Value Forecast (Million US$),2019 – 2025
Figure 6–21: Global Viread Market Value (Million US$),2015 – 2018
Figure 6–22: Global Viread Market Value Forecast (Million US$),2019 – 2025
Figure 6–23: Global Complera Market Value (Million US$),2015 – 2018
Figure 6–24: Global Complera Market Value Forecast (Million US$),2019 – 2025
Figure 6–25: Global Stribild Market Value (Million US$),2015 – 2018
Figure 6–26: Global Stribild Market Value Forecast (Million US$),2019 – 2025
Figure 6–27: Global Genvoya Market Value (Million US$),2015 – 2018
Figure 6–28: Global Genvoya Market Value Forecast (Million US$),2019 – 2025
Figure 6–29: Global Biktarvy Market Value Forecast (Million US$),2018 – 2025
Figure 6–30: Global Descovy Market Value (Million US$),2015 – 2018
Figure 6–31: Global Descovy Market Value Forecast (Million US$),2019 – 2025
Figure 6–32: Global Odefsey Market Value (Million US$),2015 – 2018
Figure 6–33: Global Odefsey Market Value Forecast (Million US$),2019 – 2025
Figure 6–34: Global Prezcobix Market Value (Million US$),2015 – 2018
Figure 6–35: Global Prezcobix Market Value (Million US$),2019 – 2025
Figure 6–36: Global Edurant Market Value (Million US$),2015 – 2018
Figure 6–37: Global Edurant Market Value Forecast (Million US$),2019 – 2025
Figure 6–38: Global Isentress Market Value (Million US$),2015 – 2018
Figure 6–39: Global Isentress Market Value Forecast (Million US$),2019 – 2025
Figure 6–40: Global Pifeltro Market Value & Forecast (Million US$),2018 – 2025
Figure 6–41: Global Delstrigo Market Value & Forecast (Million US$),2018 – 2025

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs